Navigation Links
Buckley receives American Psychiatric Association award for mentorship

AUGUSTA, Ga. - Dr. Peter F. Buckley, a psychiatrist specializing in schizophrenia and Dean of the Medical College of Georgia at Georgia Regents University, is the 2014 winner of the Kempf Fund Award for Research Development in Psychobiological Psychiatry from the American Psychiatric Association.

The award, recognizing a senior researcher and mentor who has made significant contributions to defining causes and better treatments for schizophrenia, was presented during the APA's Annual Meeting in New York.

Buckley's research focuses on the neurobiology and treatment of schizophrenia, including studies on the genetics of schizophrenia, the psychopharmacology of relapse, and cognitive retraining to improve patients' focus and function. His primary mentorship role is with Dr. Brian J. Miller, a faculty member in the MCG Department of Psychiatry and Health Behavior who came to Augusta in 2005 as a psychiatry resident to work with him. Miller studies the impact of the immune system function in schizophrenia, including its contribution to relapse and potential for predicting relapse and/or monitoring treatment results.

Buckley will receive $1,500 and Miller $20,000 to support the younger psychiatrist's research career development.

The two physician-scientists were drawn to schizophrenia work because of the complexity of the illness and the reality that many patients died 30 years prematurely, primarily from cardiovascular disease, which may be accelerated by schizophrenia treatment.

"I was very moved by their stories and by the complexity of their illness and comorbidities and saw just a real need for physicians who have a genuine interest in this patient population, so it was just kind of a natural calling," Miller said.

As a medical student at University College Dublin, Buckley first thought he would be a family physician like his father. A psychiatry rotation peaked his interest in schizophrenia and a psychiatry residency strengthened it. A faculty appointment at Case Western Reserve University and a stint as Medical Director of Western Reserve Psychiatric Hospital enabled Buckley to work alongside pioneers in the field. These included Dr. S. Charles Schulz, Case Western Department Chairman; Dr. Herbert Y. Meltzer, who co-led the benchmark study identifying the antipsychotic clozapine as the most potent schizophrenia treatment; and Dr. Dale P. Svendsen, then Medical Director of the Ohio Department of Public Health.

Miller would cross many of the same esteemed paths while in medical school and earning a master of public health at The Ohio State University. When it was time for Miller to start a residency, Svendsen suggested Miller meet Buckley.

"A good amount of what I do for him at this stage is try to connect him with other leaders in the field that he may not have a connection with and try to make sure opportunities are available to him," Buckley said. A key benchmark was securing a mentored research grant from the National Institute of Mental Health so Miller could pursue his interest in finding a safe marker for schizophrenia relapse. Next steps including securing an independent federal grant.

It's a relationship that has worked well for two very different individuals studying differing aspects of a complex disease. "A good mentor recognizes not only what your strengths and skill sets are but also your limitations and they inspire you and drive you and push you to build new skills, to take on new experiences and opportunities," Miller said. "It's kind of a bicycle built for two and they are steering you in the right direction."

Having more than one mentor helps and knowing when to get out of the way is essential as well, Buckley said. "Control is a deadly dynamic. They can't grow under the shadow of their mentor," said Buckley, who is proud of the distinct path Miller is taking. "He is carving out and has always carved out his own area and his focus is not my area. In fact, I am learning from him," Buckley said.

Buckley was named a member of the Executive Committee of the International Congress of Schizophrenia Research in 2013 and has served on its Advisory Board for nearly a decade. He is also a member of the Election Committee of the Schizophrenia International Research Society and the Scientific Council of the Brain and Behavior Research Foundation. He has served on a NIMH Special Emphasis Panel on Schizophrenia and Aging, and chaired the institute's Interventions Committee for Disorders Related to Schizophrenia, Late Life or Personality. He also serves on a NIMH Data and Safety Monitoring Board and, last year, co-chaired the federal review panel for Clinical and Translational Research Award applications.

In addition to an MD and MPH from The Ohio State University, Miller earned a PhD from Finland's University of Oulu. He completed a psychiatric residency, psychotic disorders fellowship and a year as Chief Resident at MCG and the Georgia Regents Health System before joining the faculty in 2010. He is an editorial board member of Schizophrenia Bulletin, a member of the Georgia Psychiatric Physicians Association Board of Trustees, and recipient of the 2011 Exemplary Psychiatrist Award from the National Alliance on Mental Illness, the 2013 GRU Research Institute Emerging Scientist Award, and the 2014 MCG Exemplary Teaching Award.


Contact: Toni Baker
Medical College of Georgia at Georgia Regents University

Related medicine news :

1. Sinclair Institute® Presents: Sex After Menopause Webinar hosted by Dr. Lori Buckley, Psy.D., CST
2. Loyola Cancer Center receives Outstanding Achievement Award
3. MU receives national award for using mind-body approach to improve health
4. Neuropsychologist receives University of Houstons highest faculty honor
5. Boston researcher, surgical oncologist receives national award
6. LA BioMed receives Grand Challenges Explorations grant
7. Lawson researcher receives 1 of first-ever Pfizer Psychiatry Research Awards
8. Dr. Arthur Slutsky, vice-president of research at St. Michaels, receives lifetime award
9. UC San Diego Superfund Research Program receives $15 million grant renewal
10. Markey receives $6.25 million to study deadly blood and bone marrow disease
11. Feola, at University of Kentucky, receives NIH grant to study cystic fibrosis
Post Your Comments:
Related Image:
Buckley receives American Psychiatric Association award for mentorship
(Date:11/24/2015)... ... 2015 , ... Preparing for the LDT Regulation:, CLIA Won’t Satisfy the FDA, ... , FDA has long asserted that design and manufacture of Laboratory Developed Tests (LDTs) ... not meet the device regulations. , Come up short in an inspection and the ...
(Date:11/24/2015)... Richey, FL (PRWEB) , ... November 24, 2015 , ... ... deems a growing epidemic as deaths from prescription opioids in the United States grew ... and cocaine. In 2013 alone, opioids were involved in 37 percent of all fatal ...
(Date:11/24/2015)... ... November 24, 2015 , ... American Family Care (AFC), the ... of a holiday pop-up clinic located in Metro Atlanta’s North Point Mall. The clinic ... and different way. The location is scheduled to operate through Dec. 24. , Holiday ...
(Date:11/24/2015)... CA (PRWEB) , ... November 24, 2015 , ... Cold Shoulder , LLC launched ... Kickstarter last week and hit their goal of $20,000 in under 10 hours. ... aims to bring the new PRO Weight Loss Vest to the market. , The PRO ...
(Date:11/24/2015)... ... November 24, 2015 , ... ... its exceptional customer service: the TrustDale certification. The award recognizes good companies for ... stone honing , tile and grout, and hard surface restoration company earned this ...
Breaking Medicine News(10 mins):
(Date:11/24/2015)... , November 24, 2015 F1000Workspace ... scientists - since it was launched just six months ago. ... management and authoring platform for scientists - since it was ... references have been loaded on to F1000Workspace - ... - since it was launched just six months ago. ...
(Date:11/24/2015)... , Nov. 24, 2015 iRhythm Technologies, Inc. , ... care, today announced that it will participate in the 27th Annual ... New York, NY . Kevin King ... Tuesday December 1, 2015 at 8:50am ET. ... . --> . --> ...
(Date:11/24/2015)... The uptake of recently approved and pipeline premium products for Type 1 ... 2021, says GBI Research . --> ... Diabetes Mellitus (T1DM), will be a key driver of market growth to ... The uptake of recently approved and pipeline premium products for Type ... to 2021, says GBI Research . ...
Breaking Medicine Technology: